Amsterdam, The Netherlands, March 21, 2014 (GLOBE NEWSWIRE) -- uniQure N.V. (Nasdaq:QURE), a leader in human gene therapy, today announced that its management will present a corporate overview at the 21st Annual Future Leaders in the Biotech Industry Conference March 28, 2014, to be held at the Millennium Broadway Hotel, New York City, NY, USA.
| Date: March 28, 2014 |
| Time: 11:00 a.m. (EDT) |
| Location: Millennium Broadway Hotel & Conference Center, New York City, Room 402/403 |
| Speaking: Joern Aldag, Chief Executive Officer |
To access a simultaneous webcast of Mr. Aldag's presentation via the internet, log on to the "Events" section on the Media page of the uniQure website at http://www.uniqure.com/news/calendar-of-events/.
A replay of the webcast will be available from uniQure's website for 30 days following the conference. Mr. Aldag's presentation will be available for download in PDF format immediately following the presentation in the "Events" section of the Media page of uniQure's website at http://www.uniqure.com/news/calendar-of-events/.
About uniQure
uniQure is delivering on the promise of gene therapy through single treatments with potentially curative results. We have developed a modular platform to rapidly bring new disease-modifying therapies to patients with severe disorders. We are engaged in multiple partnerships and have obtained regulatory approval of our lead product, Glybera, in the European Union for a subset of patients with LPLD. www.uniQure.com
| uniQure: |
| Aicha Diba |
| Investor Relations |
| Direct : +31 20 566 8014 |
| Main: +31 20 566 7394 |
| IR@uniQure.com |
| Media inquiries: |
| Gretchen Schweitzer |
| MacDougall Biomedical Communications |
| Direct: +49 172 861 8540 |
| Main: +1 781 235 3060 |
| gschweitzer@macbiocom.com |
HUG#1770971